Globe Life Inc. (NYSE:GL) Shares Sold by Leavell Investment Management Inc.

Leavell Investment Management Inc. lowered its position in shares of Globe Life Inc. (NYSE:GL) by 4.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 68,143 shares of the company’s stock after selling 3,013 shares during the quarter. Leavell Investment Management Inc. owned about 0.08% of Globe Life worth $7,599,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GL. CWM LLC lifted its position in Globe Life by 149.2% during the 3rd quarter. CWM LLC now owns 17,901 shares of the company’s stock worth $1,896,000 after acquiring an additional 10,717 shares during the period. Exchange Traded Concepts LLC purchased a new position in shares of Globe Life during the 3rd quarter valued at about $247,000. Creative Planning raised its stake in shares of Globe Life by 43.8% during the 3rd quarter. Creative Planning now owns 32,477 shares of the company’s stock valued at $3,440,000 after buying an additional 9,892 shares during the last quarter. nVerses Capital LLC raised its stake in shares of Globe Life by 1,150.0% during the 3rd quarter. nVerses Capital LLC now owns 2,500 shares of the company’s stock valued at $265,000 after buying an additional 2,300 shares during the last quarter. Finally, Net Worth Advisory Group purchased a new position in shares of Globe Life during the 3rd quarter valued at about $674,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on GL shares. Evercore ISI upgraded Globe Life from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. Raymond James lifted their price objective on Globe Life from $160.00 to $188.00 and gave the company a “strong-buy” rating in a research note on Tuesday, October 15th. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $135.00 to $137.00 and gave the company an “outperform” rating in a research note on Friday, January 10th. BMO Capital Markets assumed coverage on Globe Life in a research note on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price objective for the company. Finally, Jefferies Financial Group lifted their price target on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. Five analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $132.30.

Insiders Place Their Bets

In other news, CMO Jennifer Allison Haworth sold 9,000 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the transaction, the chief marketing officer now directly owns 13,485 shares in the company, valued at $1,522,591.35. The trade was a 40.03 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Frank M. Svoboda sold 14,340 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total value of $1,560,192.00. Following the transaction, the chief executive officer now owns 16,396 shares in the company, valued at approximately $1,783,884.80. This represents a 46.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 39,788 shares of company stock worth $4,429,779. Corporate insiders own 1.51% of the company’s stock.

Globe Life Price Performance

Shares of Globe Life stock opened at $121.31 on Wednesday. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. Globe Life Inc. has a twelve month low of $38.95 and a twelve month high of $132.00. The business has a 50-day moving average price of $113.67 and a 200 day moving average price of $107.57. The firm has a market cap of $10.18 billion, a PE ratio of 10.15 and a beta of 0.81.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Sell-side analysts predict that Globe Life Inc. will post 13.57 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were paid a dividend of $0.24 per share. The ex-dividend date was Monday, January 6th. This represents a $0.96 annualized dividend and a yield of 0.79%. Globe Life’s dividend payout ratio (DPR) is currently 8.03%.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.